Biomonitor
Payments companies reported to CMS as associated with Biomonitor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biomonitor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biomonitor
These are the largest totals companies reported as associated with Biomonitor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Huang | Rochester, NY | Clinical Cardiac Electrophysiology | $23,775.33 |
| Bruce Stambler | Atlanta, GA | Clinical Cardiac Electrophysiology | $17,325.00 |
| Kavita Krishnasamy | Fayetteville, GA | Clinical Cardiac Electrophysiology | $17,325.00 |
| Erden Goljo | New York, NY | Clinical Cardiac Electrophysiology | $3,338.41 |
| Gregory Harris | Greenville, NC | Clinical Cardiac Electrophysiology | $3,183.47 |
| Kelly Jia | New York, NY | Clinical Cardiac Electrophysiology | $3,160.55 |
| David Bello | Orlando, FL | Clinical Cardiac Electrophysiology | $3,077.13 |
| Antonio Moretta | Sarasota, FL | Clinical Cardiac Electrophysiology | $2,694.23 |
| Christopher Chien | Portland, OR | Advanced Heart Failure and Transplant Cardiology | $2,665.08 |
| Christopher Liu | New York, NY | Clinical Cardiac Electrophysiology | $2,531.03 |
Prescribed Biomonitor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.